Features such as PD-L1 expression, α-fetoprotein (AFP), immune gene signatures, and tumor-infiltrating lymphocytes have been studied for their potential to predict responsiveness to immunotherapy (14–16). This evidence concerns the gene CD274 and neoplasm.